These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 807887)

  • 1. Unilateral gynecomastia and impotence during low-dose spironolactone administration in men.
    Zarren HS; Black PM
    Mil Med; 1975 Jun; 140(6):417-9. PubMed ID: 807887
    [No Abstract]   [Full Text] [Related]  

  • 2. Gynecomastia and impotence: complications of spironolactone therapy.
    Greenblatt DJ; Koch-Weser J
    JAMA; 1973 Jan; 223(1):82. PubMed ID: 4739107
    [No Abstract]   [Full Text] [Related]  

  • 3. Spironolactone and endocrine dysfunction.
    Ann Intern Med; 1976 Nov; 85(5):630-6. PubMed ID: 984618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of low-dose spironolactone on resistant hypertension.
    Engbaek M; Hjerrild M; Hallas J; Jacobsen IA
    J Am Soc Hypertens; 2010; 4(6):290-4. PubMed ID: 21130975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug-induced gynecomastia].
    Schirren U; Hinz B; Schirren C
    Andrologia; 1986; 18(1):104-7. PubMed ID: 3954080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Male gynecomastia.
    Haynes BA; Mookadam F
    Mayo Clin Proc; 2009 Aug; 84(8):672. PubMed ID: 19648382
    [No Abstract]   [Full Text] [Related]  

  • 7. Eplerenone reduces morbidity and mortality after acute MI.
    Cardiovasc J S Afr; 2006; 17(5):280. PubMed ID: 17117244
    [No Abstract]   [Full Text] [Related]  

  • 8. Gynaecomastia, galactorrhoea and impotence--the uncommon side effects of cimetidine therapy.
    Jauhari J
    J Assoc Physicians India; 1987 Jun; 35(6):462. PubMed ID: 3654561
    [No Abstract]   [Full Text] [Related]  

  • 9. Gynecomastia and sexual disorders after the administration of omeprazole.
    Carvajal A; Martín Arias LH
    Am J Gastroenterol; 1995 Jun; 90(6):1028-9. PubMed ID: 7771409
    [No Abstract]   [Full Text] [Related]  

  • 10. Spironolactone-induced gynecomastia.
    Cuculi F; Suter A; Erne P
    CMAJ; 2007 Feb; 176(5):620. PubMed ID: 17325324
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gynecomastia in spironolactone therapy].
    Vetter H
    Dtsch Med Wochenschr; 1979 May; 104(21):762. PubMed ID: 446292
    [No Abstract]   [Full Text] [Related]  

  • 12. Spironolactone-induced bilateral gynecomastia in a man detected by SPECT myocardial perfusion imaging.
    Farag AA; Andrikopoulou E; Hage FG
    J Nucl Cardiol; 2017 Apr; 24(2):742. PubMed ID: 27151301
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term experience of spironolactone in essential hypertension.
    Jeunemaitre X; Kreft-Jais C; Chatellier G; Julien J; Degoulet P; Plouin PF; Ménard J; Corvol P
    Kidney Int Suppl; 1988 Oct; 26():S14-7. PubMed ID: 3199684
    [No Abstract]   [Full Text] [Related]  

  • 14. [Iatrogenic gynecomastia in aldosterone-antagonist therapy].
    Quietzsch D
    Z Gesamte Inn Med; 1981 Feb; 36(3):87-9. PubMed ID: 7222857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Can ulcer treatment with cimetidine and other H2 receptor antagonists induce sexual dysfunctions (impotence) and other endocrine disorders?].
    Barth JA
    Zentralbl Gynakol; 1991; 113(11):667. PubMed ID: 1927114
    [No Abstract]   [Full Text] [Related]  

  • 16. [Complications of verospirone therapy].
    Bokarev IN; Baranova NV
    Klin Med (Mosk); 1987 Sep; 65(9):104-8. PubMed ID: 3695298
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathophysiology of spironolactone-induced gynecomastia.
    Rose LI; Underwood RH; Newmark SR; Kisch ES; Williams GH
    Ann Intern Med; 1977 Oct; 87(4):398-403. PubMed ID: 907238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disappearance of spironolactone-induced gynecomastia with triamteren.
    Yamamoto S
    Intern Med; 2001 Jun; 40(6):550. PubMed ID: 11446686
    [No Abstract]   [Full Text] [Related]  

  • 19. Cimetidine-induced impotence and breast changes in patients with gastric hypersecretory states.
    Jensen RT; Collen MJ; Pandol SJ; Allende HD; Raufman JP; Bissonnette BM; Duncan WC; Durgin PL; Gillin JC; Gardner JD
    N Engl J Med; 1983 Apr; 308(15):883-7. PubMed ID: 6835285
    [No Abstract]   [Full Text] [Related]  

  • 20. Worsening of motor symptoms and gynecomastia during spironolactone treatment in a patient with Parkinson's disease and congestive heart failure.
    Teive HA; Munhoz RP; Werneck LC
    Mov Disord; 2007 Aug; 22(11):1678-9. PubMed ID: 17534964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.